FDA Approved: TAVALISSE — Supplemental Application (Rigel Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for TAVALISSE (fostamatinib) submitted by Rigel Pharmaceuticals, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immune Thrombocytopenia

Drugs mentioned

• Tavalisse (fostamatinib)

Snippet

SUPPL AP for TAVALISSE (FOSTAMATINIB)